1. Home
  2. Programs
  3. Medical Industry Feature

Biosimilar Access: Addressing Barriers to Build a Sustainable Marketplace

5 chapters
Play All
Details
Chapters
Recommended

Overview

Chapter 1
ReachMD Healthcare Image
RestartResume

Learn about the impacts of biosimilars on healthcare system cost savings, barriers to their adoption in the US, and potential strategies to increase marketplace sustainability.

Chapter 1

Playing

chapter item
Biosimilar Access: Addressing Barriers to Build a Sustainable Marketplace
Chapter 2

Playing

chapter item
Biosimilars in the US
Chapter 3

Playing

chapter item
Barriers to Biosimilar Adoption: Payer and PBM Tactics
Chapter 4

Playing

chapter item
Barriers to Biosimilar Adoption: Patent Thickets
Chapter 5

Playing

chapter item
Future of Biosimilars in the US
  • Sponsored by

  • Overview

    Biosimilars have greatly impacted the US healthcare system over the last decade, creating cost savings and increasing access for patients.1,2 However, although some biosimilars have seen significant adoption, not all biosimilars have been able to achieve sustainable market use.1 Learn about the barriers to biosimilar adoption in the US and strategies for overcoming them from Dr. Andre Harvin. Dr. Harvin is the chief pharmacy officer at Cone Health in Greensboro, North Carolina.

    References:

    1. AAM, The U.S. Generic & Biosimilar Medicines Savings Report, September 2023
    2. IQVIA Institute for Human Data Science, Biosimilars in the United States 2023-2027: Competition, Savings, and Sustainability, January 2023

    © Fresenius Kabi USA, LLC 2025 03/2025

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free